Laboratory Net Debt from 2010 to 2026

LH Stock

USD 278.11 11.78 4.06%

Laboratory's Net Debt is increasing with slightly volatile movements from year to year. Net Debt is estimated to finish at about 6.9 B this year. Net Debt is the total debt of Laboratory of minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1989-03-31

Previous Quarter

5.9 B

Current Value

5.9 B

Quarterly Volatility

2.4 B

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 251.5 M, Total Revenue of 15.7 B or Gross Profit of 4.4 B, as well as many indicators such as Price To Sales Ratio of 1.6, Dividend Yield of 0.0138 or PTB Ratio of 3.26. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.

Build AI portfolio with Laboratory Stock

Check out the analysis of Laboratory Correlation against competitors.

The Net Debt trend for Laboratory of offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Laboratory is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Laboratory's Net Debt Growth Pattern

Below is the plot of the Net Debt of Laboratory of over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Laboratory's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Laboratory Net Debt Regression Statistics

	Arithmetic Mean	4,713,522,985
	Coefficient Of Variation	43.50
	Mean Deviation	1,684,484,109
	Median	5,435,600,000
	Standard Deviation	2,050,151,976
	Sample Variance	4203123.1T
	Range	7B
	R-Value	0.82
	Mean Square Error	1494929T
	R-Squared	0.67
	Significance	0.000064
	Slope	331,463,017
	Total Sum of Squares	67249970T

Laboratory Net Debt History

	2026	6.9 B
	2025	6.6 B
	2024	5.8 B
	2023	5.4 B
	2022	5.9 B
	2021	4.9 B
	2020	5.4 B

Other Fundumenentals of Laboratory

Net Debt To E B I T D A

Laboratory Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.94	0.95	0.93	0.95	0.98	0.94	0.82	0.18	0.55	0.8	0.95	0.86	-0.7	0.28	0.79	-0.2	0.87	-0.53	0.52	-0.61	0.36	0.6	0.62	0.61	-0.76
Total Stockholder Equity	0.98		0.86	0.99	0.9	0.96	0.93	0.96	0.76	0.17	0.48	0.72	0.95	0.82	-0.65	0.35	0.81	-0.06	0.79	-0.62	0.42	-0.58	0.31	0.62	0.68	0.7	-0.81
Net Debt	0.94	0.86		0.81	0.88	0.82	0.98	0.79	0.86	0.17	0.59	0.87	0.86	0.87	-0.71	0.1	0.69	-0.48	0.93	-0.33	0.64	-0.58	0.39	0.4	0.41	0.32	-0.6
Retained Earnings	0.95	0.99	0.81		0.9	0.94	0.89	0.95	0.7	0.21	0.52	0.66	0.93	0.76	-0.68	0.34	0.76	0.04	0.72	-0.63	0.3	-0.53	0.31	0.64	0.71	0.71	-0.83
Accounts Payable	0.93	0.9	0.88	0.9		0.83	0.92	0.92	0.65	0.37	0.49	0.64	0.96	0.67	-0.62	0.15	0.7	-0.04	0.73	-0.57	0.43	-0.79	0.62	0.65	0.61	0.5	-0.86
Net Receivables	0.95	0.96	0.82	0.94	0.83		0.91	0.94	0.79	0.14	0.49	0.73	0.91	0.84	-0.65	0.47	0.83	-0.08	0.79	-0.58	0.42	-0.53	0.27	0.67	0.64	0.73	-0.75
Total Liab	0.98	0.93	0.98	0.89	0.92	0.91		0.9	0.84	0.19	0.6	0.84	0.92	0.87	-0.73	0.21	0.74	-0.33	0.92	-0.42	0.58	-0.61	0.4	0.56	0.56	0.5	-0.69
Total Current Assets	0.94	0.96	0.79	0.95	0.92	0.94	0.9		0.64	0.24	0.43	0.62	0.96	0.7	-0.57	0.38	0.79	0.11	0.71	-0.66	0.37	-0.68	0.46	0.8	0.78	0.77	-0.87
Intangible Assets	0.82	0.76	0.86	0.7	0.65	0.79	0.84	0.64		0.0	0.57	0.97	0.67	0.99	-0.7	0.21	0.64	-0.56	0.94	-0.21	0.61	-0.36	0.08	0.23	0.26	0.35	-0.39
Short Term Debt	0.18	0.17	0.17	0.21	0.37	0.14	0.19	0.24	0.0		0.27	-0.09	0.3	-0.06	-0.22	-0.06	-0.16	0.27	-0.05	-0.16	-0.07	-0.49	0.63	0.38	0.24	0.03	-0.42
Common Stock	0.55	0.48	0.59	0.52	0.49	0.49	0.6	0.43	0.57	0.27		0.58	0.39	0.55	-0.97	-0.15	0.03	-0.31	0.56	0.24	0.16	-0.11	0.11	0.15	0.14	0.16	-0.22
Long Term Debt	0.8	0.72	0.87	0.66	0.64	0.73	0.84	0.62	0.97	-0.09	0.58		0.64	0.96	-0.68	0.11	0.58	-0.62	0.98	-0.12	0.71	-0.34	0.05	0.21	0.27	0.33	-0.32
Property Plant Equipment	0.95	0.95	0.86	0.93	0.96	0.91	0.92	0.96	0.67	0.3	0.39	0.64		0.72	-0.55	0.31	0.81	0.01	0.73	-0.72	0.43	-0.73	0.56	0.7	0.68	0.59	-0.91
Good Will	0.86	0.82	0.87	0.76	0.67	0.84	0.87	0.7	0.99	-0.06	0.55	0.96	0.72		-0.69	0.26	0.71	-0.51	0.95	-0.29	0.62	-0.35	0.04	0.29	0.33	0.44	-0.44
Treasury Stock	-0.7	-0.65	-0.71	-0.68	-0.62	-0.65	-0.73	-0.57	-0.7	-0.22	-0.97	-0.68	-0.55	-0.69		0.02	-0.25	0.32	-0.68	-0.05	-0.23	0.2	-0.11	-0.21	-0.2	-0.27	0.36
Short Term Investments	0.28	0.35	0.1	0.34	0.15	0.47	0.21	0.38	0.21	-0.06	-0.15	0.11	0.31	0.26	0.02		0.46	0.2	0.13	-0.5	0.02	-0.01	-0.02	0.37	0.34	0.52	-0.31
Current Deferred Revenue	0.79	0.81	0.69	0.76	0.7	0.83	0.74	0.79	0.64	-0.16	0.03	0.58	0.81	0.71	-0.25	0.46		-0.07	0.67	-0.75	0.39	-0.54	0.28	0.57	0.52	0.58	-0.7
Net Tangible Assets	-0.2	-0.06	-0.48	0.04	-0.04	-0.08	-0.33	0.11	-0.56	0.27	-0.31	-0.62	0.01	-0.51	0.32	0.2	-0.07		-0.59	-0.44	-0.6	-0.11	0.21	0.43	0.41	0.41	-0.38
Long Term Debt Total	0.87	0.79	0.93	0.72	0.73	0.79	0.92	0.71	0.94	-0.05	0.56	0.98	0.73	0.95	-0.68	0.13	0.67	-0.59		-0.2	0.69	-0.44	0.15	0.33	0.36	0.38	-0.41
Capital Surpluse	-0.53	-0.62	-0.33	-0.63	-0.57	-0.58	-0.42	-0.66	-0.21	-0.16	0.24	-0.12	-0.72	-0.29	-0.05	-0.5	-0.75	-0.44	-0.2		-0.04	0.5	-0.39	-0.61	-0.61	-0.56	0.85
Deferred Long Term Liab	0.52	0.42	0.64	0.3	0.43	0.42	0.58	0.37	0.61	-0.07	0.16	0.71	0.43	0.62	-0.23	0.02	0.39	-0.6	0.69	-0.04		-0.42	0.14	0.09	0.09	0.1	-0.12
Long Term Investments	-0.61	-0.58	-0.58	-0.53	-0.79	-0.53	-0.61	-0.68	-0.36	-0.49	-0.11	-0.34	-0.73	-0.35	0.2	-0.01	-0.54	-0.11	-0.44	0.5	-0.42		-0.81	-0.69	-0.44	-0.35	0.71
Short Long Term Debt	0.36	0.31	0.39	0.31	0.62	0.27	0.4	0.46	0.08	0.63	0.11	0.05	0.56	0.04	-0.11	-0.02	0.28	0.21	0.15	-0.39	0.14	-0.81		0.56	0.34	0.04	-0.65
Cash And Equivalents	0.6	0.62	0.4	0.64	0.65	0.67	0.56	0.8	0.23	0.38	0.15	0.21	0.7	0.29	-0.21	0.37	0.57	0.43	0.33	-0.61	0.09	-0.69	0.56		0.81	0.78	-0.76
Net Invested Capital	0.62	0.68	0.41	0.71	0.61	0.64	0.56	0.78	0.26	0.24	0.14	0.27	0.68	0.33	-0.2	0.34	0.52	0.41	0.36	-0.61	0.09	-0.44	0.34	0.81		0.83	-0.73
Net Working Capital	0.61	0.7	0.32	0.71	0.5	0.73	0.5	0.77	0.35	0.03	0.16	0.33	0.59	0.44	-0.27	0.52	0.58	0.41	0.38	-0.56	0.1	-0.35	0.04	0.78	0.83		-0.6
Capital Stock	-0.76	-0.81	-0.6	-0.83	-0.86	-0.75	-0.69	-0.87	-0.39	-0.42	-0.22	-0.32	-0.91	-0.44	0.36	-0.31	-0.7	-0.38	-0.41	0.85	-0.12	0.71	-0.65	-0.76	-0.73	-0.6

Click cells to compare fundamentals

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Net Debt, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Net Debt	6.6 B	6.9 B
Net Debt To EBITDA	3.65	3.43

Currently Active Assets on Macroaxis

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill
CSAN	Cosan SA ADR
RKT	Rocket Companies

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Laboratory Correlation against competitors.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.56

Dividend Share

2.88

Earnings Share

10.2

Revenue Per Share

164.953

Quarterly Revenue Growth

0.086

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Laboratory Net Debt from 2010 to 2026

Latest Laboratory's Net Debt Growth Pattern

Laboratory Net Debt Regression Statistics

Laboratory Net Debt History

Other Fundumenentals of Laboratory

Laboratory Net Debt component correlations

About Laboratory Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY